Read an analysis on Harrow's Q3 earnings, inventory issues and strategic pivots, with a focus on VEVYE and IHEEZO's potential for recovery in Q4.

A Statistics Canada survey released this month is casting light on the experiences of Indigenous people in the healthcare ...

The FDA's REMS program has been found to have unintentionally created barriers to accessing clozapine, a crucial ...

The DEA said the third extension of these flexibilities will ensure continuity of care for providers and patients who have ...

It was a hot Wednesday afternoon. I needed to buy groceries at the popular Ebeano Supermarket inside the Ikeja GRA, Lagos ...